The Startup Using AI To Make Hearing Aids Better
In this week’s edition of InnovationRx, we look at Fortell’s efforts to make a better hearing aid, Abby Care’s business getting payment for caregivers, J&J’s $5.5 billion talc settlement, Scribe Therapeutics’ IPO, and more.
ByAmy Feldman,
Senior Editor
andAlex Knapp,
Forbes Staff
The Potential Havoc Of Generic Drug Tariffs
In this week’s edition of InnovationRx, we look at the companies looking to cash in on the coming peptide bonanza, the ongoing cyclosporiasis outbreak, Tempus’s acquisition of a cancer-testing company, and more.
ByAmy Feldman,
Senior Editor
andAlex Knapp,
Forbes Staff
Founder Of $1 Billion Cancer Care Startup Steps Down As CEO
In this week’s edition of InnovationRx, Thyme Care gets new leadership, the intestinal illness spreads, Chai Discovery confirms its $400 million raise, and more.
ByAmy Feldman,
Senior Editor
Boom Times For Autoimmune Disease Therapies
In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion purchase of Crinetics, and more.
ByAmy Feldman,
Senior Editor
Why Axsome Stock Has Doubled In Nine Months
In this week’s edition of InnovationRx, we look at Axsome’s growing pipeline, HistoSonics innovative cancer treatment, state litigation over Medicaid work requirements, and more.
ByAmy Feldman,
Senior Editor
andAlex Knapp,
Forbes Staff
AbbVie’s $11 Billion Immunology Bet
In this week’s edition of InnovationRx, we look at AbbVie’s new megadeal, an agentic AI startup saving Medicare $2 million a week, how new student loan rules could degrade healthcare and more.
ByAmy Feldman,
Senior Editor
andAlex Knapp,
Forbes Staff
The Healthcare M&A Wave
In this week’s edition of InnovationRx, we look at biotech M&A, the rise of India’s Anthem Biosciences, and more.
ByAmy Feldman,
Senior Editor
andAlex Knapp,
Forbes Staff
SpaceX’s Healthcare Plays
In this week’s edition of InnovationRx, we look at the AI drug discovery startup Lilly and Pfizer are betting on, the greatest living immigrants in healthcare and more.
ByAmy Feldman,
Senior Editor
andAlex Knapp,
Forbes Staff
AI Startup Collate Raises $95 Million To Automate Life Sciences Paperwork
In this week’s edition of InnovationRx, we look at breakthroughs from ASCO, Harrison.ai's U.S. expansion, Clear's move into healthcare and more.
ByAmy Feldman,
Senior Editor
andAlex Knapp,
Forbes Staff
Eli Lilly’s $4 Billion Vaccine Bet
In this week’s edition of InnovationRx, we look at the spreading Ebola epidemic, the Midas list health investors, Lilly’s trio of vaccine deals, and more.
ByAmy Feldman,
Senior Editor
andAlex Knapp,
Forbes Staff